The Asia Pacific enteral nutrition market was valued at US$1.79 billion in 2022 and is expected to reach US$2.94 billion by 2030; it is estimated to grow at a CAGR of 6.4% from 2022 to 2030.
The rising prevalence of neurological diseases and the growing adoption of enteral nutrition are boosting the market's growth. China has experienced a significant rise in the elderly population. Stroke is the leading cause of death among older people across the country. According to the study published in Elsevier, in 2020, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported. The factors that have affected the numbers are the support of the government to educate the public on stroke prevention, better public knowledge of stroke, improved treatment options and medical technology, and improved healthcare coverage and healthcare environment, among others. Stroke is the most common cause of acute dysphagia, which may lead to malnutrition and impact the quality of life. Tube feeding of critically ill stroke patients was implemented as an enteral nutrition improvement strategy in China.
Based on product type, the Asia Pacific enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Asia Pacific enteral nutrition market share in 2022.
In terms of application, the Asia Pacific enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Asia Pacific enteral nutrition market share in 2022.
Based on age group, the Asia Pacific enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Asia Pacific enteral nutrition market share in 2022.
By distribution channel, the Asia Pacific enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Asia Pacific enteral nutrition market share in 2022.
Based on country, the Asia Pacific enteral nutrition market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific enteral nutrition market in 2022.
Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Reckitt Benckiser Group Plc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the Asia Pacific enteral nutrition market.
Strategic Initiatives by Key Market Players Fuel Asia Pacific Enteral Nutrition Market
Companies operating in the enteral nutrition market continuously focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches. These help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the enteral nutrition market are mentioned below:- In June 2022, Nestle Health Science acquired The Better Health Company (TBHC) from CDH Investments and TBHC's founding shareholders. The acquisition includes the GO Healthy brand; vitamin and supplement lineups; Egmont, the Manuka honey brand; and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements. The acquisition helped Nestle Health Science strengthen and expand its presence in New Zealand, Australia, and other Asia Pacific countries.
- In September 2021, Abbott introduced plant-based protein and organic food ingredients-PediaSure Harvest and Ensure Harvest-for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements.
- In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company brings unique and nutritious choices to children and adults dependent on feeding tubes, in line with its real food blends mission.
- Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements, the development of innovative products targeting various health issues, and strategic moves such as expansions and acquisitions allow companies in the enteral nutrition market to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.
Asia Pacific Enteral Nutrition Market Overview
The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.The rising prevalence of neurological diseases and the growing adoption of enteral nutrition are boosting the market's growth. China has experienced a significant rise in the elderly population. Stroke is the leading cause of death among older people across the country. According to the study published in Elsevier, in 2020, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported. The factors that have affected the numbers are the support of the government to educate the public on stroke prevention, better public knowledge of stroke, improved treatment options and medical technology, and improved healthcare coverage and healthcare environment, among others. Stroke is the most common cause of acute dysphagia, which may lead to malnutrition and impact the quality of life. Tube feeding of critically ill stroke patients was implemented as an enteral nutrition improvement strategy in China.
Asia Pacific Enteral Nutrition Market Segmentation
The Asia Pacific enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.Based on product type, the Asia Pacific enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Asia Pacific enteral nutrition market share in 2022.
In terms of application, the Asia Pacific enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Asia Pacific enteral nutrition market share in 2022.
Based on age group, the Asia Pacific enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Asia Pacific enteral nutrition market share in 2022.
By distribution channel, the Asia Pacific enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Asia Pacific enteral nutrition market share in 2022.
Based on country, the Asia Pacific enteral nutrition market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific enteral nutrition market in 2022.
Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Reckitt Benckiser Group Plc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the Asia Pacific enteral nutrition market.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Enteral Nutrition Market - Key Industry Dynamics
5. Enteral Nutrition Market - Asia Pacific Market Analysis
6. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type
7. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application
8. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group
9. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel
10. Asia Pacific Enteral Nutrition Market - Country Analysis
11. Enteral Nutrition Market-Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- Arla Foods amba
- B Braun SE
- Danone SA
- Fonterra Co-Operative Group Ltd
- Fresenius SE & Co KGaA
- Nestle SA
- Perrigo Co Plc
- Reckitt Benckiser Group Plc
- Royal FrieslandCampina NV
